3rd Epigenetics in Drug Discovery conference
8th - 10th May 2013
- Organization:
- GTC
- Type:
- Conference
- Venue:
- Boston, MA, Hyatt Regency
- Location:
- 1 Ave De Lafayette, Boston, Massachusetts
- Website:
- 3rd Epigenetics in Drug Discovery conference
- Phone number:
- 6262566405
- Area
- Life Sciences
- Specialty
- Biotechnology
- Subject
- Biotechnology
Deadlines
-
Abstract Deadline:
8th April 2013 -
Registration Deadline:
10th April 2013
Speakers
Yi Zhang, Olena Barbash, Ho Man Chan, Antje Dittmann
GTC’s 3rd Epigenetics in Drug Discovery conference is the only epigenetics conference that brings together a balanced mix of leading experts from the industry and academia to collaborate on the latest cutting edge research on novel epigenetic mechanisms, therapeutics, developments, biomarkers and diagnostics. Venture Capitalists will also join the conference to discuss investment opportunities and what they look for in the epigenetics space.
Some key discussions around epigenetics drug discovery at the conference include: 1) The role of epigenetics in human diseases such as cancer, leukaemia, neurodegenerative conditions, neuropsychiatric disorders, inflammation, etc. 2) Novel mechanisms, biomarkers, technologies and diagnostics for epigenetics drug discovery 3) Cutting edge research from GlaxoSmithKline, Epizyme, Genentech, Constellation, Astex, Cellzome, RaNA Therapeutics, Pfizer, Harvard, Massachusetts Institute of Technology, etc.
Conference sessions are:
Epigenetic Mechanisms
Role of Epigenetics in Human Diseases
Drug Discovery in Epigenetics
Preclinical and Clinical Development
Epigenetic Biomarkers and Diagnostics
Panel Discussion: Investment Opportunities in the Epigenetic Space
The conference will run parallel with the other exciting conferences:
7th Drug Design & Medicinal Chemistry
6th Imaging in Drug Discovery & Development
Orphan Drugs Research and Commercialization
